Erasca to Present at Upcoming Investor Conferences in September

Rhea-AI Summary

Erasca (Nasdaq: ERAS), a clinical-stage precision oncology company, has announced its participation in two major investor conferences in September 2024. The company will present at the 22nd Annual Morgan Stanley Global Healthcare Conference on September 5 and the 2024 Cantor Global Healthcare Conference on September 18, both in New York City.

At both events, Erasca's management will engage in fireside chats and one-on-one investor meetings. The Morgan Stanley conference presentation is scheduled for 12:20 - 12:55 pm ET, while the Cantor conference slot is 3:40 - 4:10 pm ET. Live audio webcasts of these events will be available on Erasca's website, with archived replays accessible for 30 days post-event.

SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in September 2024 and will also participate in one-on-one investor meetings.

22^nd Annual Morgan Stanley Global Healthcare Conference
Location: New York Marriott Marquis, New York, NY
Format: Fireside Chat
Date and Time: Thursday, September 5, 12:20 – 12:55 pm Eastern Time

2024 Cantor Global Healthcare Conference
Location: InterContinental Barclay, New York, NY
Format: Fireside Chat
Date and Time: Wednesday, September 18, 3:40 – 4:10 pm Eastern Time

A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Erasca, Inc.

FAQ

What investor conferences will Erasca (ERAS) attend in September 2024?

Erasca (ERAS) will attend the 22nd Annual Morgan Stanley Global Healthcare Conference on September 5 and the 2024 Cantor Global Healthcare Conference on September 18, both in New York City.

When and where is Erasca's (ERAS) presentation at the Morgan Stanley conference?

Erasca's (ERAS) presentation at the Morgan Stanley conference is on Thursday, September 5, 2024, from 12:20 to 12:55 pm Eastern Time at the New York Marriott Marquis.

What is the format of Erasca's (ERAS) presentations at the September 2024 conferences?

Erasca's (ERAS) presentations at both September 2024 conferences will be in a fireside chat format, accompanied by one-on-one investor meetings.

How can investors access Erasca's (ERAS) conference presentations in September 2024?

Investors can access live audio webcasts of Erasca's (ERAS) September 2024 conference presentations at Erasca.com/events. Archived replays will be available for 30 days following each webcast.